A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Neuroendocrine Tumors
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04893759
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Minhu Chen, MD, PhD First Affiliated Hospital, Sun Yat-Sen University Principal Investigator: Jie Chen, MD, PhD First Affiliated Hospital, Sun Yat-Sen University